To prevent algorithmic bias, the authors call for multivariable modeling frameworks that jointly incorporate biological sex, genetic ancestry, and gender-related life-course exposures.
From antibiotic resistance to emerging viral threats, the global demand for new medicines is intensifying, yet traditional drug discovery pipelines remain slow and expensive. A new scientific review ...
BANGALORE, India , Feb. 17, 2026 /PRNewswire/ -- According to Valuates Reports, The global market for AI in Biotechnology was valued at USD 1033 Million in the year 2024 and is projected to reach a ...
Merck and Mayo Clinic have announced a research and development agreement to apply AI, advanced analytics and multimodal clinical data to support drug discovery and development.
Insulin resistance - when the body doesn't properly respond to insulin, a hormone that helps control blood glucose levels - ...
Two new projects are advancing rice breeding strategies to improve productivity of main and ratoon crops, and health benefits of purple rice.
Artificial Intelligence (AI)-driven gene sequencing, undertaken by the Department of Biotechnology (DBT) in Govt of India, promises to power India’s transition toward “personalised” medical ...
The search space for protein engineering grows exponentially with complexity. A protein of just 100 amino acids has 20100 possible variants—more combinations than atoms in the observable universe.
The Precision Medicine Market represents a transformative shift in global healthcare, focusing on tailoring medical treatment ...
Discover how proteomics data analysis and bioinformatics tools enhance mass spectrometry workflows for robust findings.
Healthcare Asia Magazine on MSN
AI in precision medicine market to soar to $38.9B by 2034 on 35.5% CAGR
Market growth is driven by ML, deep learning, EHR. The global artificial intelligence (AI) in precision medicine market is projected to reach $38.88b by 2034, with a compound annual growth rate of 35.
LIGAND-AI is a flagship project of the Target 2035 initiative, funded by the Innovative Health Initiative, a public-private partnership (PPP) between the European Union and the European life science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results